Clinical-stage pharmaceutical developer of a patent-protected, oral non-opioid/non-NSAID analgesic — an optimized nefopam formulation — for acute and chronic pain. Offers a novel mechanism of action intended to provide effective pain relief with reduced side effects and addiction risk.